Detection of prostate cancer relapse with PET/CT using a novel radiotracer

By Lilleby Wolfgang   Willoch Frode   Stensvold Andreas  

Acta Oncologica, Vol. 51, Iss. 3, 2012-03 ,pp. : 397-399

Informa Healthcare

Access to resources Recommend Favorite

Continuous prostate-specific antigen rise despite salvage radiotherapy following radical prostatectomy: Pattern of clinical relapse and predictive factors

By          

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1138-1142

Spandidos Publications

Access to resources Recommend Favorite

Value of PSA (Prostate-specific Antigen) in the Detection of Prostate Cancer in Patients with Urological Symptoms. Results of a Multicentre Study

By Cooperative Group for the Diagnosis of Prostate Cancer   Filella X.   Molina R.   Ballesta A.M.   Gil M.J.   Allepuz C.   Rioja L.A.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1125-1128

Elsevier

Access to resources Recommend Favorite

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

By Kupelian P.A.   Elshaikh M.   Reddy C.A.   Zippe C.   Klein E.A.   Ritter M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 308-309

Elsevier

Access to resources Recommend Favorite

Synthesis and positron emission tomography evaluation of 18F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer

By                

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2299-2302

Spandidos Publications

Access to resources Recommend Favorite